Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 3
1977 3
1978 2
1979 2
1980 4
1981 2
1983 1
1984 1
1985 3
1986 3
1987 1
1988 1
1989 4
1990 4
1991 5
1992 5
1993 3
1994 6
1995 8
1996 5
1997 6
1998 5
1999 5
2000 3
2001 5
2002 5
2003 2
2005 1
2007 2
2009 2
2010 3
2011 2
2012 3
2013 2
2014 1
2017 1
2019 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Gene therapy of ovarian cancer.
Bauknecht T, Meinhold-Heerlein I. Bauknecht T, et al. Curr Womens Health Rep. 2002 Feb;2(1):39-46. Curr Womens Health Rep. 2002. PMID: 12112982 Review.
The stilbestrol-adenosis-carcinoma syndrome.
Hillemanns HG, Bauknecht T, Simmer H. Hillemanns HG, et al. Among authors: bauknecht t. Obstet Gynecol Surv. 1979 Nov;34(11):814-7. doi: 10.1097/00006254-197911000-00009. Obstet Gynecol Surv. 1979. PMID: 523019 Free article.
[Torre-Muir syndrome].
Hagedorn M, Bauknecht T, Russwurm R. Hagedorn M, et al. Among authors: bauknecht t. Hautarzt. 1987 Nov;38(11):683-6. Hautarzt. 1987. PMID: 3429231 German.
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.
Ressing ME, van Driel WJ, Brandt RM, Kenter GG, de Jong JH, Bauknecht T, Fleuren GJ, Hoogerhout P, Offringa R, Sette A, Celis E, Grey H, Trimbos BJ, Kast WM, Melief CJ. Ressing ME, et al. Among authors: bauknecht t. J Immunother. 2000 Mar-Apr;23(2):255-66. doi: 10.1097/00002371-200003000-00010. J Immunother. 2000. PMID: 10746552
Clinical phase I study with one-hour paclitaxel infusion.
Mross K, Hauns B, Häring B, Bauknecht T, Meerpohl HG, Unger C, Maier-Lenz H. Mross K, et al. Among authors: bauknecht t. Ann Oncol. 1998 May;9(5):569-72. doi: 10.1023/a:1008217429971. Ann Oncol. 1998. PMID: 9653500 Free article. Clinical Trial.
Phase II study of gemcitabine in ovarian cancer.
von Minckwitz G, Bauknecht T, Visseren-Grul CM, Neijt JP. von Minckwitz G, et al. Among authors: bauknecht t. Ann Oncol. 1999 Jul;10(7):853-5. doi: 10.1023/a:1008364327684. Ann Oncol. 1999. PMID: 10470434 Free article. Clinical Trial.
Survey of genital lichen sclerosus in women and men.
Hagedorn M, Buxmeyer B, Schmitt Y, Bauknecht T. Hagedorn M, et al. Among authors: bauknecht t. Arch Gynecol Obstet. 2002 Apr;266(2):86-91. doi: 10.1007/s004040100209. Arch Gynecol Obstet. 2002. PMID: 12049302
Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer.
Meinhold-Heerlein I, Stenner-Liewen F, Liewen H, Kitada S, Krajewska M, Krajewski S, Zapata JM, Monks A, Scudiero DA, Bauknecht T, Reed JC. Meinhold-Heerlein I, et al. Among authors: bauknecht t. Am J Pathol. 2001 Apr;158(4):1335-44. doi: 10.1016/S0002-9440(10)64084-9. Am J Pathol. 2001. PMID: 11290551 Free PMC article.
112 results